A2A is a startup based in the United States, 1 tracked investor.
A2A is a startup founded in 2017 based in the United States. Brouky records 1 investor associated with the company.
A2A develops pharmaceuticals, focusing on clinical-stage drug candidates to treat respiratory and infectious diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.